EMR's stock price has plunged by more than 25% in 2015. Many of the company's markets are being impacted by falling oil prices, sluggish industrial spending trends, manufacturing weakness in China, and a strong US dollar. We believe the company's dividend is very safe and will continue to grow each year, maintaining EMR's status as one of the 52 dividend aristocrats.
Beyond the dividend, we think EMR's current stock price offers attractive returns for long-term dividend investors who are willing to wait out volatility in the company's markets. With so much attention being given to EMR's challenging markets and dismal outlook for the next year, we believe the company's restructuring activities, significant portfolio realignment, and opportunity for long-term earnings...

